Community Engagement
In March 2016 SATVI brought "Lienkie se Longe", a drama to raise awareness about TB, to the Worcester Easter Festival. The drama tells the story of Lienkie, whose lungs “talk with each other’ about their health and the health of Lienkie’s boyfriend...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
In 2012 SATVI developed a drama production to promote awareness about TB vaccine clinical research, titled “Carina’s Choice” with learners from Worcester Secondary School as actors and UCT drama school students as mentors. A very successful roadshow...
Accredited UCT Research Centre
The South African Tuberculosis Vaccine Initiative (SATVI) is an accreditated Research Centre of the University of Cape Town.
Kick TB Schools Program 17- 27 May 2016
On Tuesday 17 May 2016, SATVI kicked off a districtwide TB awareness raising program, in partnership with TB Alliance, the Western Cape Education Department, AERAS, TB Care (USAID), in Robertson.


Monday, 25 September 2017
21 September 2017 Vacancy Research Officer: Systems Immunology

SATVI invites applications for the position of Research Officer: Systems Immunology at its Cape Town offices.

Publication Date:
Thursday, September 21, 2017 - 18:15
14 September 2017 Latest Research: Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population

SATVI authors have published a research paper titled: "Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population" appearing in the PLoS ONE Journal.

Publication Date:
Friday, September 15, 2017 - 09:00
8 September 2017 Latest Research: A Functional Toll-Interacting Protein Variant associated with Bacillus Calmette-Guerin Specific Immune Response and Tuberculosis

Professor Mark Hatherill and Associate Professor Tom Scriba have co-authored a research paper titled "A Functional Toll-interacting Protein variant with Bacillus Calmette-Guerin specific immune responses and Tuberculosis" appearing in the American Journal of Respiratory and Critical Care Medicine.

Publication Date:
Friday, September 8, 2017 - 08:00
7 September 2017 Research Published: Identifying specificity groups in T cell receptor repertoire

Associate Professor Tom Scriba has co-authored a research paper titled "Identifying specificity groups in the T Cell receptor repertoire" appearing in the Nature Journal.

Publication Date:
Thursday, September 7, 2017 - 17:15